R. Raghunandan

发表

A Newcastle disease virus expressing a stabilized spike protein of SARS-CoV-2 induces protective immune responses

A. García-Sastre, P. Palese, I. González-Domínguez, 2021, Nature Communications.

A Newcastle disease virus-vector expressing a prefusion-stabilized spike protein of SARS-CoV-2 induces protective immune responses against prototype virus and variants of concern in mice and hamsters

A. García-Sastre, P. Palese, I. González-Domínguez, 2021, bioRxiv.

The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio of neutralizing to non-neutralizing antibodies in humans as compared to mRNA vaccines

J. Wrammert, D. Sather, A. García-Sastre, 2022, medRxiv.

Safety and immunogenicity of an inactivated recombinant Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomised, placebo-controlled, phase 1 trial

S. Lamola, M. Lal, P. Pitisuttithum, 2022, eClinicalMedicine.

Safety and Immunogenicity of an Inactivated Recombinant Newcastle Disease Virus Vaccine Expressing SARS-CoV-2 Spike: Interim Results of a Randomised, Placebo-Controlled, Phase 1/2 Trial

S. Lamola, M. Lal, P. Pitisuttithum, 2021, medRxiv.

Safety and immunogenicity of an egg-based inactivated Newcastle disease virus vaccine expressing SARS-CoV-2 spike: Interim results of a randomized, placebo-controlled, phase 1/2 trial in Vietnam

M. Lal, J. McLellan, A. García-Sastre, 2022, Vaccine.

A study on complications and management of pseudo cysts of pancreas: At tertiary care hospital

R. Raghunandan, 2019, International Journal of Surgery Science.

RSV neutralization assays - Use in immune response assessment.

Deborah Higgins, N. Hosken, R. Raghunandan, 2021, Vaccine.

An inactivated NDV-HXP-S COVID-19 vaccine elicits a higher proportion of neutralizing antibodies in humans than mRNA vaccination

J. Wrammert, D. Sather, P. Pitisuttithum, 2023, Science Translational Medicine.

Coverage and Effectiveness of Kyasanur Forest Disease (KFD) Vaccine in Karnataka, South India, 2005–10

M. Murhekar, S. Mehendale, R. Raghunandan, 2013, PLoS neglected tropical diseases.

Kyasanur Forest Disease, India, 2011–2012

M. Murhekar, S. Mehendale, P. Yadav, 2013, Emerging infectious diseases.

The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio 1 of neutralizing to non-neutralizing antibodies in humans as compared to mRNA 2 vaccines 3

J. Wrammert, D. Sather, P. Pitisuttithum, 2022 .

The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio 1 of neutralizing to non-neutralizing antibodies in humans as compared to mRNA 2 vaccines 3

J. Wrammert, D. Sather, P. Pitisuttithum, 2022 .

The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio 1 of neutralizing to non-neutralizing antibodies in humans as compared to mRNA 2 vaccines 3

J. Wrammert, D. Sather, P. Pitisuttithum, 2022 .

The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio 1 of neutralizing to non-neutralizing antibodies in humans as compared to mRNA 2 vaccines 3

J. Wrammert, D. Sather, P. Pitisuttithum, 2022 .

The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio 1 of neutralizing to non-neutralizing antibodies in humans as compared to mRNA 2 vaccines 3

J. Wrammert, D. Sather, P. Pitisuttithum, 2022 .

The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio 1 of neutralizing to non-neutralizing antibodies in humans as compared to mRNA 2 vaccines 3

J. Wrammert, D. Sather, P. Pitisuttithum, 2022 .

The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio 1 of neutralizing to non-neutralizing antibodies in humans as compared to mRNA 2 vaccines 3

J. Wrammert, D. Sather, P. Pitisuttithum, 2022 .

The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio 1 of neutralizing to non-neutralizing antibodies in humans as compared to mRNA 2 vaccines 3

J. Wrammert, D. Sather, P. Pitisuttithum, 2022 .

The inactivated NDV-HXP-S COVID-19 vaccine induces a significantly higher ratio 1 of neutralizing to non-neutralizing antibodies in humans as compared to mRNA 2 vaccines 3

J. Wrammert, D. Sather, P. Pitisuttithum, 2022 .

Hyperphosphorylation of human TAU by brain kinase PK40erk beyond phosphorylation by cAMP-dependent PKA: relation to Alzheimer's disease.

V. Ingram, B. Blanchard, H. Roder, 1994, Biochemical and biophysical research communications.